Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide (Retraction in: Journal of Clinical Oncology (2010) 28:25 (4018))

Journal of Clinical Oncology

Volumn 13, Issue 8, 1995, Pages 2072-2076

  Chamberlain, Marc C ^a,b   Grafe, Marjorie R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DEXAMETHASONE; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; LOMUSTINE; MITOLACTOL; NITROSOUREA DERIVATIVE; PLATINUM; PROCARBAZINE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ALOPECIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; FEMALE; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; MALE; NEURORADIOLOGY; NEUTROPENIA; OPTIC CHIASM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 0029095594     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1995.13.8.2072     Document Type: Article

References (42)

1. Hoyt WF, Bagdassarian SA: Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol 53:793-798, 1969
2. Packer RJ, Sutton LN, Bilaniuk LT, et al: Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: An updated report. Ann Neurol 23:79-85, 1988
3. Weiss L, Sagerman RH, King GA, et al: Controversy in the management of optic nerve glioma. Cancer 59:1000-1004, 1987
4. Petronio J, Edwards MSB, Prados M, et al: Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg 74:701-708, 1991
5. Bataini JP, Delanian S, Ponvert D: Chiasmal gliomas: Results of irradiation management in 57 patients and review of literature. Int J Radiat Oncol Biol Phys 21:615-623, 1991
6. Janss A, Grundy R, Phillips P, et al: Optic pathway and hypothalamic gliomas in children under age 5: Management and outcome. Proc Am Soc Clin Oncol 12:175, 1993 (abstr)
7. Wong JYC, Uhl V, Wara WM, et al: Optic gliomas, a reanalysis of the University of California, San Francisco experience. Cancer 60:1847-1855, 1987
8. Rodriguez LA, Edwards MSB, Levin VA: Management of hypothalamic gliomas in children: An analysis of 33 cases. Neurosurgery 26:242-247, 1990 (suppl 2)
9. Spoor TC, Kennerdell JS, Martinez AJ, et al: Malignant gliomas of the optic nerve pathways. Am J Ophthalmol 89:284-292, 1980
10. Imes RK, Hoyt W: Childhood chiasmal gliomas: Update on the fate of patients in the 1969 San Francisco study. J Ophthalmol 70:179-182, 1986 (suppl 3)
11. Packer RJ, Savino PJ, Bilaniuk LT, et al: Chiasmatic gliomas of childhood: A reappraisal of natural history and effectiveness of cranial irradiation. Childs Brain 10:393-403, 1983
12. Fletcher WA, Imes RK, Hoyt WF: Chiasmal gliomas: Appearance and long-term changes demonstrated by computerized tomography. J Neurosurg 65:154-159, 1986
13. Packer RJ, Lange B, Ater J, et al: Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850-856, 1993
14. Iraci G, Gerosa M, Tomazzoli L, et al: Gliomas of the optic nerve and chiasm: A clinical review. Childs Brain 8:326-349, 1981
15. Dosoretz DE, Blitzer PH, Wang CC, et al: Management of glioma of the optic nerve and/or chiasm: An analysis of 20 cases. Cancer 45:1467-1471, 1980
16. Rush JA, Younge BR, Campbell RJ, et al: Optic glioma. Long-term follow-up of 85 histopathologically verified cases. Ophthalmology 89:1213-1219, 1982
17. Iraci G, Gerosa M, Tomazzoli A: Anterior optic gliomas of childhood. Childs Brain 8:326-349, 1981
18. Oxenhandler DC, Sayers MP: The dilemma of childhood optic gliomas. J Neurosurg 48:34-41, 1978
19. Tenny RT, Laws ER, Younge BR, et al: The neurosurgical management of optic glioma: Results in 104 patients. J Neurosurg 57:452-458, 1982
20. Rosenstock JG, Packer RJ, Bilaniuk L, et al: Chiasmatic optic glioma treated with chemotherapy: A preliminary report. J Neurosurg 63:862-866, 1985
21. Dutton JJ: Optic nerve gliomas and meningiomas. Neuroophthalmol 9:163-177, 1991
22. Danoff BF, Kramer S, Thompson N: The radiotherapeutic management of optic nerve gliomas in children. Int J Radiat Oncol Biol Phys 6:45-50, 1979
23. Kovalic JJ, Grigsby PW, Shepard MJ, et al: Radiation therapy for gliomas of the optic nerve and chiasm. Int J Radiat Oncol Biol Phys 18:927-932, 1989
24. Pierce SM, Barnes PD, Loeffler JS, et al: Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer 65:45-52, 1990
25. Capo H, Kupersmith MJ: Efficacy and complications of radiotherapy of anterior visual pathway tumors. Neuroophthalmol 9:179-203, 1991 (suppl 1)
26. Moghrabi A, Friedman HS, Burger PC, et al: Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg 79:223-227, 1993
27. Horwich A, Bloom HJG: Optic gliomas: Radiation therapy and prognosis. Int J Radiat Oncol Biol Phys 11:1067-1079, 1985
28. Wisoff JH, Abbott R, Epstein F: Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 73:661-667, 1990
29. Chamberlain MC, Levin VA: Chemotherapeutic treatment of the diencephalic syndrome. Cancer 63:1681-1684, 1989
30. Packer RJ, Finlay J, Lange B, et al: Efficacy of chemotherapy with carboplatin and vincristine for children with low-grade gliomas. Ann Neurol 32:48-57, 1992 (suppl 3)
31. de los A, Pons M, Finlay JL, et al: Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma. J Neurooncol 14:151-158, 1992
32. Housepian EM, Chi TL: Neurofibromatosis and optic pathways gliomas. J Neurooncol 15:51-55, 1993
33. Stern J, DiGiacinto GV, Housepian EM: Neurofibromatosis and optic glioma: Clinical and morphological correlations. Neurosurg 4:524-528, 1979
34. Listernick R, Charrow J, Greenwald MJ, et al: Optic gliomas in children with neurofibromatosis type 1. J Pediatr 114:788-792, 1989
35. Lansky LL, List MA, Lansky SB, et al: Toward the development of a play performance scale of children (PPSC). Cancer 56:1837-1840, 1985
36. Clark PI, Slevin ML: The clinical pharmacology of etoposide and teniposide. Clin Pharm 12:223-252, 1987
37. Slevin ML: The clinical pharmacology of etoposide. Cancer 67:319-329, 1991
38. Creaven PJ: The clinical pharmacology of VM-26 and VP-16-213: A brief overview. Cancer Chemother Pharmacol 7:133-140, 1982
39. Greco FA: Future directions for etoposide therapy. Cancer 67:315-318, 1991
40. Greco FA, Johnson DH, Hainsworth JD: Chronic oral etoposide. Cancer 67:303-309, 1991
41. Chamberlain MC: Recurrent brainstem gliomas treated with oral VP-16. J Neurooncol 15:133-139, 1993
42. Meadows AT, Baum E, Fossati-Bellani F, et al: Second malignant neoplasms in children: An update from the late effects study group. J Clin Oncol 3:532-538, 1985